Glycosaminoglycan and proteoglycan inhibit the depolymerization of β2-microglobulin amyloid fibrils in vitro
- 1 September 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 64 (3) , 1080-1088
- https://doi.org/10.1046/j.1523-1755.2003.00167.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mapping the core of the β2-microglobulin amyloid fibril by H/D exchangeNature Structural & Molecular Biology, 2002
- β2-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitroJournal of Molecular Biology, 2001
- Amyloid-β Interactions with Chondroitin Sulfate-derived Monosaccharides and DisaccharidesJournal of Biological Chemistry, 2001
- Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril StabilityJournal of Neurochemistry, 1997
- Ultrastructural organization of hemodialysis-associated β2-microglobulin amyloid fibrilsKidney International, 1997
- Concentration-Dependent Inhibitory Effects of Apolipoprotein E on Alzheimer's β-Amyloid Fibril Formation in VitroBiochemistry, 1997
- Establishment of a kinetic model of dialysis-related amyloid fibril extensionin vitroAmyloid, 1997
- Proteoglycan-mediated Inhibition of Aβ ProteolysisJournal of Biological Chemistry, 1995
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985